Our Mission
The Oxford Vaccine Group has been at the forefront of vaccine development for 30 years, helping to fight diseases of major global importance through research and education around the world.
What's Happening?
Study Spotlight
Calling Tiny Heroes: Join The STELLAR Study for Better Nose Vaccines!
| STELLAR👤 2- 5 years old 📅 2 visits over 28 days 💉 1 vaccination 🧬 This study will compare the protective response to infections (also called an immune response) in the nose to the protective response in the blood following vaccination with a safe and effective nasal influenza vaccine ⓘ Study visits will be in the participant’s own homes. |
Be a Vaccine Hero
Take part in a study
Could you be a Vaccine Hero by taking part in one of our clinical trials? Find out about the trials and studies currently looking for volunteers, as well as what it is like taking part from previous participants
Study - LEGACY02
A study examining lymph node cells to assess how age affects immune responses to a new vaccine.
Study - RESPECCT
A challenge study to investigate RSV and SPN co-infection to understand how these two common germs alter the nose environment and impact human health.
Study - MAGIC-01
A study of a new vaccine against Marburg Virus
Research at OVG
Education, Learning and Public Involvement
Latest Publications
⠀⠀⠀⠀⠀
-
Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved.
Journal article
Aksöz M. et al, (2024), Sci Immunol, 9
-
RSV and rhinovirus increase pneumococcal carriage acquisition and density, whereas nasal inflammation is associated with bacterial shedding.
Journal article
Mitsi E. et al, (2024), Cell Host Microbe
-
Pandemic preparedness: Why humanities and social sciences matter
Journal article
FRAMPTON S. et al, (2024), Frontiers in Public Health, 12
-
Pandemic Preparedness: Why Humanities and Social Sciences Matter
Journal article
FRAMPTON S. et al, (2024), Frontiers in Public Health
Working Together
OVG is proud to lead the National Immunisation Schedule Evaluation Consortium II (NISEC II), a collaboration between a network of Academic Clinical Research groups and the UK Health Security Agency.
